In this study, we sought to generate IgE antibodies with targeted glycosylation profiles and to examine their functional activities using a trastuzumab equivalent monoclonal IgE antibody recognizing the breast cancer antigen HER2 (HER2-IgE) as a model. This evidence concerns the gene IGHE and breast cancer.